ET Net News Agency reported on the 30th: A-share markets opened mixed this morning, with the Shanghai Composite Index up 0.27% at midday to 3,840.83 points, while the Shenzhen Component Index and ChiNext turned negative during the session, closing down 0.06% and 0.17% respectively. Combined turnover in the two markets reached 909.3 billion yuan (RMB, same as below) in the morning session, up 33.1 billion yuan or 3.8% compared to the same period on the previous trading day.
China's Ministry of Finance and other departments unveiled a package of incremental policy measures aimed at unlocking domestic demand potential and ensuring the annual economic growth target is achieved. One of the core policies is mortgage interest subsidies. The real estate sector surged yesterday but saw a broad pullback this morning, although it gradually stabilized during the session, with the sector index up 1.3% at midday. On the individual stock level, gainers outnumbered decliners, among which Binjiang Group (SZ:002244) rose 8.4% and Vanke A (SZ:000002) gained 3.9%.
In addition, the PBOC synchronously adjusted monetary policy tools, expanding credit disbursement and providing targeted support to key real economy sectors, cutting the PSL interest rate by 0.25 percentage points and including the 'six networks' within the PSL support scope. Bank stocks rose over 1% in the morning session, with China Merchants Bank (SH:600036) closing up 1.5% and Industrial and Commercial Bank of China (SH:601398) rising 1.4%.
Meanwhile, the pharmaceutical sector also gained on external momentum, with Tiantuo Medbot (SH:688806) hitting a 20% daily limit. News emerged that U.S. pharmaceutical company Summit Therapeutics secured a $2 billion strategic equity investment from AstraZeneca, with both parties planning to further advance clinical exploration of combination therapies involving Ivoctroban and a series of AstraZeneca's ADC drugs and other oncology treatments. (ry)
China's Ministry of Finance and other departments unveiled a package of incremental policy measures aimed at unlocking domestic demand potential and ensuring the annual economic growth target is achieved. One of the core policies is mortgage interest subsidies. The real estate sector surged yesterday but saw a broad pullback this morning, although it gradually stabilized during the session, with the sector index up 1.3% at midday. On the individual stock level, gainers outnumbered decliners, among which Binjiang Group (SZ:002244) rose 8.4% and Vanke A (SZ:000002) gained 3.9%.
In addition, the PBOC synchronously adjusted monetary policy tools, expanding credit disbursement and providing targeted support to key real economy sectors, cutting the PSL interest rate by 0.25 percentage points and including the 'six networks' within the PSL support scope. Bank stocks rose over 1% in the morning session, with China Merchants Bank (SH:600036) closing up 1.5% and Industrial and Commercial Bank of China (SH:601398) rising 1.4%.
Meanwhile, the pharmaceutical sector also gained on external momentum, with Tiantuo Medbot (SH:688806) hitting a 20% daily limit. News emerged that U.S. pharmaceutical company Summit Therapeutics secured a $2 billion strategic equity investment from AstraZeneca, with both parties planning to further advance clinical exploration of combination therapies involving Ivoctroban and a series of AstraZeneca's ADC drugs and other oncology treatments. (ry)
